Recipharm Pharmaservices Private Limited

Form 483 issued February 13, 2020 · Bengaluru, India

Inspection
Feb 10 – Feb 13, 2020
Investigator
Jason R. Caballero
Observations
1
Pages
2
FEI number
3009150119

In short: On February 13, 2020, FDA issued a Form 483 with 1 observation to Recipharm Pharmaservices Private Limited in Bengaluru, Karnataka (FEI 3009150119) after an inspection that ran Feb 10 – Feb 13, 2020. The investigator was Jason R. Caballero. Most observations concern facilities & equipment; the most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment).

At a glance

1 of 1 observations on this 483 concern facilities & equipment.

Facilities & equipment1

Most cited: 21 CFR 211.68(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Routine inspection and checking of automatic, mechanical and electronic equipment is not performed according to a…

The full 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Recipharm Pharmaservices Private Limited?

FDA listed 1 observation on this Form 483, mostly about facilities & equipment. The most-cited regulation is 21 CFR 211.68 (automatic, mechanical, and electronic equipment). The opening words of each observation are shown on this page.

Who inspected Recipharm Pharmaservices Private Limited?

Jason R. Caballero is named on this Form 483, for the inspection of Feb 10 – Feb 13, 2020. Each investigator has a profile showing what they cite most.

When was Recipharm Pharmaservices Private Limited inspected by FDA?

The inspection ran Feb 10 – Feb 13, 2020, and the Form 483 is dated February 13, 2020.

How do I get the full Form 483 for Recipharm Pharmaservices Private Limited?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free